JHJean de Dieu Habimana

Jean de Dieu Habimana

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jean de Dieu Habimana has a total of 57 co-authors. Here are the top co-authors by number of shared publications:

  • Zhiyuan Li

    Department of Anatomy and Neurobiology, Xiangya School of Medicine, Central South University, Changsha, China

    5 shared publications
  • Omar Mukama

    CAS Key Laboratory of Regenerative Biology, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China

    3 shared publications
  • Rongqi Huang

    CAS Key Laboratory of Regenerative Biology, Guangdong Provincial Key Laboratory of Stem Cell and Regenerative Medicine, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China

    3 shared publications
  • Chengrong Nie

    School of Food Science and Engineering, Foshan University/South China Food Safety Research Center, Foshan 528231, P.R. China

    2 shared publications
  • Ling Wang

    Division of Life Sciences and Medicine, University of Science and Technology of China, hefei, China

    2 shared publications
  • Lingwen Zeng

    School of Food Science and Engineering, Foshan University, Foshan 528231, China

    2 shared publications

Latest Publications

  • Open Access

    STING agonist diABZI enhances the cytotoxicity of T cell towards cancer cells

    by Ling Wang, Zhaoduan Liang, Yunzhuo Guo, Jean de Dieu Habimana, Yuefei Ren, Obed Boadi Amissah, Omar Mukama, Siqi Peng, Xuanyan Ding, Linshuang Lv, et al.

    Antigen-specific T cell receptor-engineered T cell (TCR-T) based immunotherapy has proven to be an effective method to combat cancer. In recent years, cross-talk between the innate and adaptive immune systems may be requisite to optimize sustained antigen-specific immunity, and the stimulator of interferon genes (STING) is a promising therapeutic target for cancer immunotherapy. The level of expression or presentation of antigen in tumor cells affects the recognition and killing of tumor cells by TCR-T. This study aimed at investigating the potential of innate immune stimulation of T cells and engineered T cells to enhance immunotherapy for low-expression antigen cancer cells. We systematically investigated the function and mechanism of cross-talk between STING agonist diABZI and adaptive immune systems. We established NY-ESO-1 full knockout Mel526 cells for this research and found that diABZI activated STING media and TCR signaling pathways. In addition, the results of flow cytometry showed that antigens presentation from cancer cells induced by STING agonist diABZI also improved the affinity of TCR-T cells function against tumor cells in vitro and in vivo. Our findings revealed that diABZI enhanced the immunotherapy efficacy of TCR-T by activating STING media and TCR signaling pathways, improving interferon-γ expression, and increasing antigens presentation of tumor cells. This indicates that STING agonist could be used as a strategy to promote TCR-T cancer immunotherapy.


  • A Rationally Designed CRISPR/Cas12a Assay Using a Multimodal Reporter for Various Readouts

    by Jean de Dieu Habimana, Omar Mukama, Obed Boadi Amissah, Yirong Sun, Eric Karangwa, Yujie Liu, Samson Mugisha, Na Cheng, Ling Wang, Jianlin Chen, et al.

    The CRISPR/Cas systems offer a programmable platform for nucleic acid detection, and CRISPR/Cas-based diagnostics (CRISPR-Dx) have demonstrated the ability to target nucleic acids with greater accuracy and flexibility. However, due to the configuration of the reporter and the underlying labeling mechanism, almost all reported CRISPR-Dx rely on a single-option readout, resulting in limitations in end-point result readouts. This is also associated with high reagent consumption and delays in diagnostic reports due to protocol differences. Herein, we report for the first time a rationally designed Cas12a-based multimodal universal reporter (CAMURE) with improved sensitivity that harnesses a dual-mode reporting system, facilitating options in end-point readouts. Through systematic configurations and optimizations, our novel universal reporter achieved a 10-fold sensitivity enhancement compared to the DETECTR reporter. Our unique and versatile reporter could be paired with various readouts, conveying the same diagnostic results. We applied our novel reporter for the detection of staphylococcal enterotoxin A due to its high implication in staphylococcal food poisoning. Integrated with loop-mediated isothermal amplification, our multimodal reporter achieved 10 CFU/mL sensitivity and excellent specificity using a real-time fluorimeter, in-tube fluorescence, and lateral flow strip readouts. We also propose, using artificially contaminated milk samples, a fast (2-5 min) Triton X-100 DNA extraction approach with a comparable yield to the commercial extraction kit. Our CAMURE could be leveraged to detect all gene-encoding SEs by simply reprogramming the guide RNA and could also be applied to the detection of other infections and disease biomarkers.


  • Harnessing enhanced CRISPR/Cas12a trans-cleavage activity with extended reporters and reductants for early diagnosis of Helicobacter pylori, the causative agent of peptic ulcers and stomach cancer

    by Jean de Dieu Habimana, Omar Mukama, Guiquan Chen, Mengjun Chen, Obed Boadi Amissah, Lin Wang, Yujie Liu, Yirong Sun, Amy L. Li, Sihao Deng, et al.


  • Mechanistic insights of CRISPR/Cas nucleases for programmable targeting and early-stage diagnosis: A review

    by Jean de Dieu Habimana, Rongqi Huang, Bertrand Muhoza, Yvan Ndayambaje Kalisa, Xiaobo Han, Weiyue Deng, Zhiyuan Li


  • Open Access

    Rational Programming of Cas12a for Early-Stage Detection of COVID-19 by Lateral Flow Assay and Portable Real-Time Fluorescence Readout Facilities

    by Zhijian Yi, Jean de Dieu Habimana, Omar Mukama, Zhiyuan Li, Nelson Odiwuor, Hanzhi Jing, Chengrong Nie, Mei Hu, Zuoxian Lin, Hongping Wei, et al.

    Coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 virus has led to a global pandemic with a high spread rate and pathogenicity. Thus, with limited testing solutions, it is imperative to develop early-stage diagnostics for rapid and accurate detection of SARS-CoV-2 to contain the rapid transmission of the ongoing COVID-19 pandemic. In this regard, there remains little knowledge about the integration of the CRISPR collateral cleavage mechanism in the lateral flow assay and fluorophotometer. In the current study, we demonstrate a CRISPR/Cas12a-based collateral cleavage method for COVID-19 diagnosis using the Cas12a/crRNA complex for target recognition, reverse transcription loop-mediated isothermal amplification (RT-LAMP) for sensitivity enhancement, and a novel DNA capture probe-based lateral flow strip (LFS) or real-time fluorescence detector as the parallel system readout facility, termed CRICOLAP. Our novel approach uses a customized reporter that hybridizes an optimized complementary capture probe fixed at the test line for naked-eye result readout. The CRICOLAP system achieved ultra-sensitivity of 1 copy/µL in ~32 min by portable real-time fluorescence detection and ~60 min by LFS. Furthermore, CRICOLAP validation using 60 clinical nasopharyngeal samples previously verified with a commercial RT-PCR kit showed 97.5% and 100% sensitivity for S and N genes, respectively, and 100% specificity for both genes of SARS-CoV-2. CRICOLAP advances the CRISPR/Cas12a collateral cleavage result readout in the lateral flow assay and fluorophotometer, and it can be an alternative method for the decentralized field-deployable diagnosis of COVID-19 in remote and limited-resource locations.


  • Open Access

    The Extraction, Functionalities and Applications of Plant Polysaccharides in Fermented Foods: A Review

    by Theoneste Niyigaba, Diru Liu, Jean De Dieu Habimana

    Plant polysaccharides, as prebiotics, fat substitutes, stabilizers, thickeners, gelling agents, thickeners and emulsifiers, have been immensely studied for improving the texture, taste and stability of fermented foods. However, their biological activities in fermented foods are not yet properly addressed in the literature. This review summarizes the classification, chemical structure, extraction and purification methods of plant polysaccharides, investigates their functionalities in fermented foods, especially the biological activities and health benefits. This review may provide references for the development of innovative fermented foods containing plant polysaccharides that are beneficial to health.


  • Open Access

    A CRISPR/Cas12a Based Universal Lateral Flow Biosensor for the Sensitive and Specific Detection of African Swine-Fever Viruses in Whole Blood

    by Jinghua Wu, Omar Mukama, Wei Wu, Zhiyuan Li, Jean De Dieu Habimana, Yinghui Zhang, Rong Zeng, Chengrong Nie, Lingwen Zeng

    Cross-border pathogens such as the African swine fever virus (ASFV) still pose a socio-economic threat. Cheaper, faster, and accurate diagnostics are imperative for healthcare and food safety applications. Currently, the discovery of the Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) has paved the way for the diagnostics based on Cas13 and Cas12/14 that exhibit collateral cleavage of target and single-stranded DNA (ssDNA) reporter. The reporter is fluorescently labeled to report the presence of a target. These methods are powerful; however, fluorescence-based approaches require expensive apparatuses, complicate results readout, and exhibit high-fluorescence background. Here, we present a new CRISPR–Cas-based approach that combines polymerase chain reaction (PCR) amplification, Cas12a, and a probe-based lateral flow biosensor (LFB) for the simultaneous detection of seven types of ASFV. In the presence of ASFVs, the LFB responded to reporter trans-cleavage by naked eyes and achieved a sensitivity of 2.5 × 10−15 M within 2 h, and unambiguously identified ASFV from swine blood. This system uses less time for PCR pre-amplification and requires cheaper devices; thus, it can be applied to virus monitoring and food samples detection.


  • Minireview: Trends in Optical-Based Biosensors for Point-Of-Care Bacterial Pathogen Detection for Food Safety and Clinical Diagnostics

    by Jean de Dieu Habimana, Jian Ji, Xiulan Sun

    This review considers the evolution of optical-based biosensors for bacterial pathogen detection as the causative agents for different diseases. Conventional identification and detection techniques are tedious, expensive and time-consuming, typically requiring sample pretreatment and hours to days to provide the results. For the successful monitoring of bacterial pathogen infection, fast, accurate, cost-effective and reliable techniques to simultaneously detect multiple bacterial pathogens and microbial metabolites are of the utmost importance in fields such as the food industry and healthcare. In addition, miniaturized, small amount of sample, easy to use with minimal accessories, and portable device should take advantage for rapid and point-of-care (POC) diagnosis. Optical transduction plays a substantial character in the development of such miniaturized and integrated biosensors as the alternatives to conventional analytical methods. In this review, we consider trends in point-of-care bacterial pathogen detection, different biorecognition elements, immobilization techniques, and optical based transduction methods applied for bacterial pathogen detection along with the respective advantages and drawbacks of each technique. Moreover, some examples of recently reported techniques for point-of-care analysis are also discussed. The analytical performance and characteristics of an ideal biosensor are discussed based on literature biosensor descriptions.